9996.HKEarningsprnewswire

Peijia Medical Announces 2025 Interim Results

Sentiment:Negative (10)

Summary

HONG KONG, Aug. 25, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced financial results for the six months ended June 30, 2025 ("the Reporting Period") on...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 25, 2025 by prnewswire

    Peijia Medical Announces 2025 Interim Results | 9996.HK Stock News | Candlesense